Allarity Therapeutics, Inc.

Allarity Therapeutics, Inc.verified

ALLR

Price:

$1.43

Market Cap:

$22.75M

Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new cancer treatments. They utilize a unique "drug response predictor" technology to generate specific companion diagnostics, aiming to identify which patients will best respond to their various oncology therapeutics. The company's portfolio of investigational drugs for various cancers includes: Stenoparib: A poly-ADP-ribose polymerase (PARP) inhibitor currently in Phase 2 clinical trials for ovarian cancer. Dovitinib: A pan-tyrosine kinase inhibitor designed to treat renal cell carcinoma. IXEMPRA: A microtubule inhibitor used in the treatment of metastatic breast cancer. LiPlaCis: A liposomal for...[Read more]

Industry

Biotechnology

IPO Date

2021-12-21

Stock Exchange

NASDAQ

Ticker

ALLR

The PE Ratio as of June 2026 (TTM) for Allarity Therapeutics, Inc. (ALLR) is -2.04

According to Allarity Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.04. This represents a change of 25.54% compared to the average of -1.62 of the last 4 quarters.

Allarity Therapeutics, Inc. (ALLR) Historical PE Ratio (quarterly & annually)

How has ALLR PE Ratio performed in the past?

The mean historical PE Ratio of Allarity Therapeutics, Inc. over the last ten years is -5445.05. The current -2.04 PE Ratio has changed -96.25% with respect to the historical average. Over the past ten years (40 quarters), ALLR's PE Ratio was at its highest in in the June 2016 quarter at 0. The PE Ratio was at its lowest in in the June 2020 quarter at -719798.86.

Quarterly (TTM)
Annual

Average

-5445.05

Median

-46.77

Minimum

-46515.47

Maximum

0

Allarity Therapeutics, Inc. (ALLR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Allarity Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = 0

Minimum Annual Increase = 0%

Minimum Annual PE Ratio = -46515.47

Quarterly (TTM)
Annual
YearPE RatioChange
2025-1.381.70%
2024-0.08-99.92%
2023-92.16-47.12%
2022-174.30-92.96%
2021-2475.58-52.31%
2020-5191.54-88.84%
2019-46515.47-Infinity%
201800%
201700%
201600%

Allarity Therapeutics, Inc. (ALLR) Average PE Ratio

How has ALLR PE Ratio performed in the past?

The current PE Ratio of Allarity Therapeutics, Inc. (ALLR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-31.21

5-year avg

-548.70

10-year avg

-5445.05

Allarity Therapeutics, Inc. (ALLR) PE Ratio vs. Peers

How is ALLR’s PE Ratio compared to its peers?

Allarity Therapeutics, Inc.’s PE Ratio is less than Cingulate Inc. (-0.96), less than Processa Pharmaceuticals, Inc. (-0.40), less than BriaCell Therapeutics Corp. (-0.64), less than Lexaria Bioscience Corp. (-1.58), greater than Entero Therapeutics, Inc. (-2.70), greater than Lixte Biotechnology Holdings, Inc. (-9.27), less than Clearside Biomedical, Inc. (-0.06), less than Kairos Pharma, Ltd. (-1.58), greater than Curis, Inc. (-3.85), less than CASI Pharmaceuticals, Inc. (-0.07),

Build a custom stock screener for Allarity Therapeutics, Inc. (ALLR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Allarity Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Allarity Therapeutics, Inc. (ALLR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Allarity Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Allarity Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Allarity Therapeutics, Inc. (ALLR)?

What is the highest PE Ratio for Allarity Therapeutics, Inc. (ALLR)?

What is the 3-year average PE Ratio for Allarity Therapeutics, Inc. (ALLR)?

What is the 5-year average PE Ratio for Allarity Therapeutics, Inc. (ALLR)?

How does the current PE Ratio for Allarity Therapeutics, Inc. (ALLR) compare to its historical average?